Abdomen

Venous Stents Market to Reach $2,809.7 Million by 2030, Growing at a Robust 10.40% CAGR, backed by Increasing Adoption of Outpatient Procedures and Daycare Surgeries, States Kings Research

Retrieved on: 
Tuesday, January 30, 2024

Based on application, the venous stents market is categorized into leg, chest, abdomen, and others.

Key Points: 
  • Based on application, the venous stents market is categorized into leg, chest, abdomen, and others.
  • The leg segment is anticipated to lead the global market, accruing USD 1175.6 million in revenue by 2030.
  • The escalating trend toward outpatient procedures and day surgery is a significant driving factor for the increased demand for venous stents.
  • The emergence of bio-absorbable stents and the growing adoption of drug-eluting stents are poised to create new opportunities for the venous stents market in the future.

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Retrieved on: 
Monday, January 22, 2024

Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the publication of a peer-reviewed article in the Aesthetic Surgery Journal Open Forum, which evaluated the use of Renuvion for contracting subcutaneous soft tissue following liposuction in multiple areas of the body.

Key Points: 
  • Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the publication of a peer-reviewed article in the Aesthetic Surgery Journal Open Forum, which evaluated the use of Renuvion for contracting subcutaneous soft tissue following liposuction in multiple areas of the body.
  • “We are excited to see the publication of this real-world 483-patient analysis, demonstrating Renuvion’s impressive safety when used after liposuction, which is now the most commonly performed cosmetic procedure in the world.,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical.
  • Additionally, they concluded that the risks associated with the use of Renuvion for subcutaneous soft tissue contraction following liposuction do not differ significantly by body area.
  • A digital version of the clinical publication is available via the following link: https://doi.org/10.1093/asjof/ojad112

Tacoma Resident Files Lawsuit Against City Following Devastating Incident with Police Vehicle, According to Osborn Machler

Retrieved on: 
Monday, January 22, 2024

Anthony Huff-McKay, a 24-year-old Tacoma resident, today filed a lawsuit against the City of Tacoma following a distressing incident where he was run over and severely injured by a patrol vehicle driven by Tacoma Police Officer Khan Phan.

Key Points: 
  • Anthony Huff-McKay, a 24-year-old Tacoma resident, today filed a lawsuit against the City of Tacoma following a distressing incident where he was run over and severely injured by a patrol vehicle driven by Tacoma Police Officer Khan Phan.
  • According to Austin Neff, an attorney with Osborn Machler who filed the suit on behalf of Huff-McKay, the legal action underscores significant concerns regarding police conduct and emphasizes the urgent need for systemic changes in law enforcement training and accountability.
  • The suit claims the car meet attendees gathered in an intersection and tensions rose as Phan attempted to push through the crowd of pedestrians using his patrol car.
  • “This case is a stark reminder of the grave consequences of inadequate police training and accountability.

Public advisory - Pediatrix Acetaminophen Oral Solution for children: One lot recalled due to potential risk of overdose

Retrieved on: 
Wednesday, January 17, 2024

Children may be especially at risk of the effects of acetaminophen overdose given their small size and developing bodies.

Key Points: 
  • Children may be especially at risk of the effects of acetaminophen overdose given their small size and developing bodies.
  • Signs of acetaminophen overdose include nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach.
  • Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours.
  • Given the limited scope of the recall, it will not have any impact on the general availability of children's acetaminophen products.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

Retrieved on: 
Tuesday, January 9, 2024

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 32, Status: Authorised

Retrieved on: 
Tuesday, January 9, 2024

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 32, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 32, Status: Authorised

Feier Unveils the Smart Somatosensory Slide Board: A Different Fitness Experience

Retrieved on: 
Monday, January 8, 2024

HONG KONG, Jan. 8, 2024 /PRNewswire/ -- Feier, a leading innovator in the fitness industry, has announced the launch of their highly anticipated Smart Somatosensory Slide Board. This remarkable fitness device combines traditional exercise with technology to provide an engaging and data-driven approach to fitness. The introduction of somatosensory gaming, real-time data tracking, and expert coaching has redefined the fitness journey, making it more interactive and effective than ever before.

Key Points: 
  • Moreover, the Smart Somatosensory Slide Board is set to revolutionize the way individuals approach fitness.
  • Whether it's in the comfort of your home, at the office, or at the local gym, the Feier Smart Somatosensory Slide Board can be your ideal fitness companion.
  • Delve deeper into the innovative features that make the Feier Smart Somatosensory Slide Board a game-changer in the fitness realm:
    Interactive Fitness Experience: Engage in somatosensory gaming and real-time data tracking for an immersive workout session.
  • For more information on the Feier Smart Somatosensory Slide Board, please visit www.feierfitness.com or contact [email protected] for inquiries.

Vitenas Cosmetic Surgery in Houston, TX Announces Cutting-Edge Technology and Its Accredited Houston Surgery Center

Retrieved on: 
Monday, January 8, 2024

HOUSTON, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Leading Cosmetic Surgery and Skincare by Dr. Paul Vitenas in Houston

Key Points: 
  • Vitenas Cosmetic Surgery announces comprehensive skincare and state-of-the-art cosmetic surgery for patients in Houston, Texas.
  • HOUSTON, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Leading Cosmetic Surgery and Skincare by Dr. Paul Vitenas in Houston
    Vitenas Cosmetic Surgery focuses on providing patients with the highest standards of cosmetic surgery and skincare.
  • The center is home to the Houston Surgery Center , a fully accredited ambulatory surgical care facility designed by Dr. Vitenas himself.
  • The center is dedicated to Vitenas Cosmetic Surgery patients and gives them privacy, convenience, and a focus on safety.